Rana Atique Anwer, Sajid Ghafor, Huma Ahmad. Neoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer. Pakistan Journal of Medical & Health Sciences [Internet]. 2022 Sep. 20 [cited 2024 Aug. 17];16(08):356. Available from: https://pjmhsonline.com/index.php/pjmhs/article/view/2384